Cargando…

Effects of Xiaoshuan Enteric-Coated Capsule on White and Gray Matter Injury Evaluated by Diffusion Tensor Imaging in Ischemic Stroke

Xiaoshuan enteric-coated capsule (XSECC) is a drug approved by the Chinese State Food and Drug Administration for the treatment of stroke. This study was to investigate the effects of XSECC on white and gray matter injury in a rat model of ischemic stroke by diffusion tensor imaging (DTI) and histop...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jian, Chen, Shengpan, Shi, Weilong, Li, Manzhong, Zhan, Yu, Yang, Le, Zou, Haiyan, Lei, Jianfeng, Chai, Xinlou, Gao, Kuo, Liu, Junjie, Wang, Wei, Wang, Yong, Zhao, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686435/
https://www.ncbi.nlm.nih.gov/pubmed/30284459
http://dx.doi.org/10.1177/0963689718802755
_version_ 1783442565122490368
author Zhang, Jian
Chen, Shengpan
Shi, Weilong
Li, Manzhong
Zhan, Yu
Yang, Le
Zou, Haiyan
Lei, Jianfeng
Chai, Xinlou
Gao, Kuo
Liu, Junjie
Wang, Wei
Wang, Yong
Zhao, Hui
author_facet Zhang, Jian
Chen, Shengpan
Shi, Weilong
Li, Manzhong
Zhan, Yu
Yang, Le
Zou, Haiyan
Lei, Jianfeng
Chai, Xinlou
Gao, Kuo
Liu, Junjie
Wang, Wei
Wang, Yong
Zhao, Hui
author_sort Zhang, Jian
collection PubMed
description Xiaoshuan enteric-coated capsule (XSECC) is a drug approved by the Chinese State Food and Drug Administration for the treatment of stroke. This study was to investigate the effects of XSECC on white and gray matter injury in a rat model of ischemic stroke by diffusion tensor imaging (DTI) and histopathological analyses. The ischemia was induced by middle cerebral artery occlusion (MCAO). The cerebral blood flow measured by arterial spin labeling was improved by treatment with XSECC on the 3rd, 7th, 14th and 30th days after MCAO. Spatiotemporal white and gray matter changes in MCAO rats were examined with DTI-derived parameters (fractional anisotropy, FA; apparent diffusion coefficient, ADC; axial diffusivity, λ(//); radial diffusivity, λ(⊥)). The increased FA was found in the XSECC treatment group in the corpus callosum, external capsule and internal capsule, linked with the decreased λ(//), λ(⊥) and ADC on the 3rd day and reduced ADC on the 30th day in the external capsule, suggesting XSECC reduced the axon and myelin damage in white matter after stroke. The relative FA in the striatum, cortex and thalamus in XSECC treatment group was significantly increased on the 3rd, 7th, 14th and 30th days accompanied by the increased λ(//) on the 3rd day and reduced relative ADC and λ(⊥) on the 30th day, indicating that XSECC attenuated cell swelling and membrane damage in the early stage and tissue liquefaction necrosis in the late stage in gray matter after stroke. Additionally, XSECC-treated rats exhibited increased mean fiber length assessed by diffusion tensor tractography. Moreover, histopathological analyses provided evidence that XSECC relieved nerve cell and myelin damage in white and gray matter after stroke. Our research reveals that XSECC could alleviate white and gray matter injury, especially reducing nerve cell damage and promoting the repair of axon and myelin after ischemic stroke.
format Online
Article
Text
id pubmed-6686435
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-66864352019-08-20 Effects of Xiaoshuan Enteric-Coated Capsule on White and Gray Matter Injury Evaluated by Diffusion Tensor Imaging in Ischemic Stroke Zhang, Jian Chen, Shengpan Shi, Weilong Li, Manzhong Zhan, Yu Yang, Le Zou, Haiyan Lei, Jianfeng Chai, Xinlou Gao, Kuo Liu, Junjie Wang, Wei Wang, Yong Zhao, Hui Cell Transplant Original Articles Xiaoshuan enteric-coated capsule (XSECC) is a drug approved by the Chinese State Food and Drug Administration for the treatment of stroke. This study was to investigate the effects of XSECC on white and gray matter injury in a rat model of ischemic stroke by diffusion tensor imaging (DTI) and histopathological analyses. The ischemia was induced by middle cerebral artery occlusion (MCAO). The cerebral blood flow measured by arterial spin labeling was improved by treatment with XSECC on the 3rd, 7th, 14th and 30th days after MCAO. Spatiotemporal white and gray matter changes in MCAO rats were examined with DTI-derived parameters (fractional anisotropy, FA; apparent diffusion coefficient, ADC; axial diffusivity, λ(//); radial diffusivity, λ(⊥)). The increased FA was found in the XSECC treatment group in the corpus callosum, external capsule and internal capsule, linked with the decreased λ(//), λ(⊥) and ADC on the 3rd day and reduced ADC on the 30th day in the external capsule, suggesting XSECC reduced the axon and myelin damage in white matter after stroke. The relative FA in the striatum, cortex and thalamus in XSECC treatment group was significantly increased on the 3rd, 7th, 14th and 30th days accompanied by the increased λ(//) on the 3rd day and reduced relative ADC and λ(⊥) on the 30th day, indicating that XSECC attenuated cell swelling and membrane damage in the early stage and tissue liquefaction necrosis in the late stage in gray matter after stroke. Additionally, XSECC-treated rats exhibited increased mean fiber length assessed by diffusion tensor tractography. Moreover, histopathological analyses provided evidence that XSECC relieved nerve cell and myelin damage in white and gray matter after stroke. Our research reveals that XSECC could alleviate white and gray matter injury, especially reducing nerve cell damage and promoting the repair of axon and myelin after ischemic stroke. SAGE Publications 2018-10-04 2019-06 /pmc/articles/PMC6686435/ /pubmed/30284459 http://dx.doi.org/10.1177/0963689718802755 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Articles
Zhang, Jian
Chen, Shengpan
Shi, Weilong
Li, Manzhong
Zhan, Yu
Yang, Le
Zou, Haiyan
Lei, Jianfeng
Chai, Xinlou
Gao, Kuo
Liu, Junjie
Wang, Wei
Wang, Yong
Zhao, Hui
Effects of Xiaoshuan Enteric-Coated Capsule on White and Gray Matter Injury Evaluated by Diffusion Tensor Imaging in Ischemic Stroke
title Effects of Xiaoshuan Enteric-Coated Capsule on White and Gray Matter Injury Evaluated by Diffusion Tensor Imaging in Ischemic Stroke
title_full Effects of Xiaoshuan Enteric-Coated Capsule on White and Gray Matter Injury Evaluated by Diffusion Tensor Imaging in Ischemic Stroke
title_fullStr Effects of Xiaoshuan Enteric-Coated Capsule on White and Gray Matter Injury Evaluated by Diffusion Tensor Imaging in Ischemic Stroke
title_full_unstemmed Effects of Xiaoshuan Enteric-Coated Capsule on White and Gray Matter Injury Evaluated by Diffusion Tensor Imaging in Ischemic Stroke
title_short Effects of Xiaoshuan Enteric-Coated Capsule on White and Gray Matter Injury Evaluated by Diffusion Tensor Imaging in Ischemic Stroke
title_sort effects of xiaoshuan enteric-coated capsule on white and gray matter injury evaluated by diffusion tensor imaging in ischemic stroke
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686435/
https://www.ncbi.nlm.nih.gov/pubmed/30284459
http://dx.doi.org/10.1177/0963689718802755
work_keys_str_mv AT zhangjian effectsofxiaoshuanentericcoatedcapsuleonwhiteandgraymatterinjuryevaluatedbydiffusiontensorimaginginischemicstroke
AT chenshengpan effectsofxiaoshuanentericcoatedcapsuleonwhiteandgraymatterinjuryevaluatedbydiffusiontensorimaginginischemicstroke
AT shiweilong effectsofxiaoshuanentericcoatedcapsuleonwhiteandgraymatterinjuryevaluatedbydiffusiontensorimaginginischemicstroke
AT limanzhong effectsofxiaoshuanentericcoatedcapsuleonwhiteandgraymatterinjuryevaluatedbydiffusiontensorimaginginischemicstroke
AT zhanyu effectsofxiaoshuanentericcoatedcapsuleonwhiteandgraymatterinjuryevaluatedbydiffusiontensorimaginginischemicstroke
AT yangle effectsofxiaoshuanentericcoatedcapsuleonwhiteandgraymatterinjuryevaluatedbydiffusiontensorimaginginischemicstroke
AT zouhaiyan effectsofxiaoshuanentericcoatedcapsuleonwhiteandgraymatterinjuryevaluatedbydiffusiontensorimaginginischemicstroke
AT leijianfeng effectsofxiaoshuanentericcoatedcapsuleonwhiteandgraymatterinjuryevaluatedbydiffusiontensorimaginginischemicstroke
AT chaixinlou effectsofxiaoshuanentericcoatedcapsuleonwhiteandgraymatterinjuryevaluatedbydiffusiontensorimaginginischemicstroke
AT gaokuo effectsofxiaoshuanentericcoatedcapsuleonwhiteandgraymatterinjuryevaluatedbydiffusiontensorimaginginischemicstroke
AT liujunjie effectsofxiaoshuanentericcoatedcapsuleonwhiteandgraymatterinjuryevaluatedbydiffusiontensorimaginginischemicstroke
AT wangwei effectsofxiaoshuanentericcoatedcapsuleonwhiteandgraymatterinjuryevaluatedbydiffusiontensorimaginginischemicstroke
AT wangyong effectsofxiaoshuanentericcoatedcapsuleonwhiteandgraymatterinjuryevaluatedbydiffusiontensorimaginginischemicstroke
AT zhaohui effectsofxiaoshuanentericcoatedcapsuleonwhiteandgraymatterinjuryevaluatedbydiffusiontensorimaginginischemicstroke